bioRxiv · 10.1101/2024.10.04.616448
Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC
Abstract
The SARS-CoV-2 KP.3.1.1 lineage is currently the dominating lineage on several continents. In parallel, the XEC lineage, a recombinant of KS.1.1 and KP.3.3, is on track of becoming the next dominant lineage in Europe and North America. Here we performed a rapid virological characterisation of the XEC lineage and studied the impact of JN.1 mRNA booster vaccination on KP.3.1.1 and XEC neutralisation.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Arora, P., Happle, C., Kempf, A., Nehlmeier, I., Stankov, M. V., Dopfer-Jablonka, A., Behrens, G. M. N., Poehlmann, S., Hoffmann, M.. 2024-10-04. Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC. https://doi.org/10.1101/2024.10.04.616448
Cite the original work for its findings. Save a collection to share your selection of sources.